Molecular Partners AG
Stock Forecast, Prediction & Price Target
Molecular Partners AG Financial Estimates
Molecular Partners AG Revenue Estimates
Molecular Partners AG EBITDA Estimates
Molecular Partners AG Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $9.33M N/A | $189.55M 1931.68% | $7.03M -96.28% | Avg: $18.66M Low: $1.60M High: $35.71M avg. 165.14% | Avg: $17.79M Low: $2.94M High: $32.64M avg. -4.66% | Avg: $71.30M Low: $11.79M High: $130.83M avg. 300.82% | Avg: $114.09M Low: $18.87M High: $209.33M avg. 60.00% |
Net Income
% change YoY
| $-63.78M N/A | $117.85M 284.76% | $-61.98M -152.59% | Avg: $-61.78M Low: $-72.60M High: $-37.43M avg. 0.32% | Avg: $-81.00M Low: $-80.01M High: $-50.52M avg. -31.10% | Avg: $-63.87M Low: $-133.18M High: $5.42M avg. 21.15% | Avg: $-45.17M Low: $-94.20M High: $3.83M avg. 29.26% |
EBITDA
% change YoY
| $-60.76M N/A | $120.12M 297.70% | $-59.53M -149.55% | Avg: $-12.56M Low: $-24.04M High: $-1.08M avg. 78.89% | Avg: $-11.97M Low: $-21.97M High: $-1.98M avg. 4.66% | Avg: $-48.00M Low: $-88.08M High: $-7.94M avg. -300.82% | Avg: $-76.81M Low: $-140.93M High: $-12.70M avg. -59.99% |
EPS
% change YoY
| -$2.06 N/A | $3.63 276.21% | -$1.89 -152.06% | Avg: -$1.68 Low: -$2.22 High: -$1.14 avg. 11.16% | Avg: -$1.99 Low: -$2.44 High: -$1.54 avg. -18.62% | Avg: -$1.95 Low: -$4.06 High: $0.17 avg. 2.14% | Avg: -$1.38 Low: -$2.87 High: $0.12 avg. 29.26% |
Operating Expenses
% change YoY
| $72.74M N/A | $72.94M 0.26% | $20.30M -72.16% | Avg: $24.07M Low: $2.07M High: $46.08M avg. 18.60% | Avg: $22.95M Low: $3.79M High: $42.11M avg. -4.66% | Avg: $92.01M Low: $15.22M High: $168.82M avg. 300.82% | Avg: $147.22M Low: $24.35M High: $270.12M avg. 60.00% |
FAQ
What is Molecular Partners AG stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of 4.90% in 2025-2028.
We have gathered data from 2 analysts. Their low estimate is -72.60M, average is -61.78M and high is -37.43M.
What is Molecular Partners AG stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of 130.32% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $1.60M, average is $18.66M and high is $35.71M.
What is Molecular Partners AG stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of 5.98% in 2025-2028.
We have gathered data from 2 analysts. Their low earnings per share estimate is -$2.22, average is -$1.68 and high is $-1.14.